Navigation Links
Isis Pharmaceuticals and BioMed Realty Trust Celebrate Grand Opening of New R&D Facility in Carlsbad, California
Date:9/20/2011

unning new facility," said City of Carlsbad Mayor Matt Hall.  "The city is proud of the partnership we've enjoyed with Isis Pharmaceuticals and BioMed Realty Trust to take this building from concept to today's grand opening in less than two years."

The building was designed to be science-centric with modern design features to foster interdisciplinary collaborations, including ample space to promote innovation, creative use of outdoor space that provides informal meeting areas for people to exchange ideas, bright and innovative laboratories with modern mobile bench cabinetry that can be moved to accommodate scientists' needs, and a fitness course that surrounds the entire campus. In addition, the eco-friendly campus includes environmentally sensitive design features, including solar panels, maximum use of natural lighting, and drought-resistant native landscaping designed to take advantage of the City of Carlsbad's local water reclamation plant. The building is expected to qualify for Silver LEED® certification from the U.S. Green Building Council.

Speaking on behalf of BioMed, Mr. Gold remarked, "The grand opening of this magnificent 176,000 square foot laboratory and office facility is the culmination of strong collaboration with Isis, one of our most valued long-term tenants. We salute Dr. Crooke and all of the Isis team, are proud to play a part in fulfilling their mission to create a healthier future, and look forward to supporting their real estate needs in Carlsbad for many years to come."

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in properties comprising approximately 12.3 mil
'/>"/>

SOURCE BioMed Realty Trust, Inc.; Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... June 29, 2015  New guidelines released today ... Association give hope for better outcomes to the ... acute ischemic stroke each year. Stryker,s Trevo ® ... used in the clinical trials that provided data ... guidelines strongly recommend endovascular therapy with stent retrievers ...
(Date:6/29/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... public offering of units. Each unit will consist of ... purchase common stock and Series B warrants to purchase ... offering would result in them beneficially owning more than ...
(Date:6/29/2015)... June 29, 2015  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... Officer and Chief Financial Officer, will present at the ... 2015 at 8:00 a.m. ET at Le Parker Meridien ... The presentation will be webcast live and will ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3
... a Standard of Care, WASHINGTON, March 17 ... the Society of Interventional,Radiology,s 33rd Annual Scientific Meeting show ... up a blood clot in most patients,much quicker than ... guided,directly to the clot via a catheter in the ...
... on Outcomes of New Analyses or Confirmatory Trial, ... Tuesday March 18, 2008, BERKELEY HEIGHTS, N.J., ... announced that the Food and Drug,Administration,s (FDA) Center ... available data are not adequate to support approval ...
Cached Medicine Technology:New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 2New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 3New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 4New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 2FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 3FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 4FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 6
(Date:6/30/2015)... , ... June 30, 2015 , ... ... game’s most advanced protection at less thickness than any other padding in football. ... in impact protection and shock absorption, Gameday Armour is engineered with D3O protective ...
(Date:6/30/2015)... ... June 30, 2015 , ... Experts estimate that up ... life. Back pain can range from a dull, constant ache (chronic) to a sudden ... epidural steroid injections, selective nerve root blocks and rhizotomy treatment, OPTIMAL Pain ...
(Date:6/30/2015)... ... , ... People who want to learn more about the ... experience (NDE) – and also want to understand why the military isn’t recognizing ... invited to visit https://zoom.us/webinar/register/f4a12556fe7c03f5dc2040ba88984b7b and RSVP their attendance at a special ...
(Date:6/30/2015)... ... ... When it comes to volunteering abroad, not many people end up doing ... high. However, there are affordable programs to be had such as those provided by ... such volunteer named Uzma Aishah, a student at the International Medical University in Malaysia, ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... AvePoint, ... the general availability of three new apps – AvePoint Watermark, AvePoint ... With the addition of these apps, workers can better streamline everyday business operations and ...
Breaking Medicine News(10 mins):Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 2Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 3Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 4
... from Matigara, Darjeeling District in West Bengal & Kuttanad in ... H7) as per report received from High Animal Security Disease ... reported from these two places. ,In Matigara, ... death of 2500 birds on 5-6th May, 2007. A team ...
... in a support group after diagnosis, use of support ... survivors receive referrals to such programs from their physicians, ... finds that cancer survivors are more likely to attend ... conditions, but there is little active support for such ...
... A leading expert in Germany has spawned a major ... tonnes of methane into the atmosphere every year ... Keppler of the Max Planck Institute for Chemistry has ... January 2006 that they had detected methane exhaled from ...
... women with a history of migraine and other headaches are ... the eye which can lead to severe vision problems ... to a study published in the May 15, 2007, issue ... Neurology. ,For the study, researchers reviewed the headache ...
... conducted to understand dietary patterns and chronic obstructive pulmonary ... halves the chances of developing progressive inflammatory lung disease ... an umbrella term for chronic progressive lung disease, such ... tracked the health of almost 43,000 men, who were ...
... infant mortality, cancer, accidental death, and diabetes than any other ... to a state health official, the Sioux Falls Argus Leader ... Department, at the request of the Zaniya Task Force, recently ... the state's population and found what he called "very somber ...
Cached Medicine News:Health News:Psychosocial Support for Cancer Survivors Needs Strengthening 2Health News:Scientists Saying Against Trees Sparks Debate 2Health News:Mid-Life Headaches May Increase Risk of Vision Problems 2Health News:American Indians in South Dakota Have More Health Problems Than Others in State, Nationwide, Health Official Says 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: